These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 20399893)

  • 21. Phospholipase D and cell signaling.
    Billah MM
    Curr Opin Immunol; 1993 Feb; 5(1):114-23. PubMed ID: 8383981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.
    Butterfield DA; Bader Lange ML; Sultana R
    Biochim Biophys Acta; 2010 Aug; 1801(8):924-9. PubMed ID: 20176130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is amyloid-β harmful to the brain? Insights from human imaging studies.
    Jagust W
    Brain; 2016 Jan; 139(Pt 1):23-30. PubMed ID: 26614753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease.
    Poirier J
    Trends Mol Med; 2003 Mar; 9(3):94-101. PubMed ID: 12657430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teneurins and Alzheimer's disease: a suggestive role for a unique family of proteins.
    Bastías-Candia S; Braidy N; Zolezzi JM; Inestrosa NC
    Med Hypotheses; 2015 Apr; 84(4):402-7. PubMed ID: 25665860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.
    Nguyen TT; Ta QTH; Nguyen TKO; Nguyen TTD; Giau VV
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Ageing and Oxidative Stress in Regulation of Amyloid-Degrading Enzymes and Development of Neurodegeneration.
    Nalivaeva NN; Turner AJ
    Curr Aging Sci; 2017; 10(1):32-40. PubMed ID: 27834125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of ischemic neuronal cell death--with relevance to Alzheimer's disease.
    Hayashi T; Shoji M; Abe K
    Curr Alzheimer Res; 2006 Sep; 3(4):351-8. PubMed ID: 17017865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A "protease activation cascade" in the pathogenesis of Alzheimer's disease.
    Nixon RA
    Ann N Y Acad Sci; 2000; 924():117-31. PubMed ID: 11193788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease: its origin at the membrane, evidence and questions.
    Buchet R; Pikuła S
    Acta Biochim Pol; 2000; 47(3):725-33. PubMed ID: 11310972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of glycosphingolipids and therapeutic perspectives on Alzheimer's disease.
    Mutoh T; Hirabayashi Y; Mihara T; Ueda M; Koga H; Ueda A; Kokura T; Yamamoto H
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):375-80. PubMed ID: 16918389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease and Abeta toxicity: from top to bottom.
    Small DH; Mok SS; Bornstein JC
    Nat Rev Neurosci; 2001 Aug; 2(8):595-8. PubMed ID: 11484003
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration.
    Stephenson D; Rash K; Smalstig B; Roberts E; Johnstone E; Sharp J; Panetta J; Little S; Kramer R; Clemens J
    Glia; 1999 Aug; 27(2):110-28. PubMed ID: 10417811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies.
    Maloney MT; Bamburg JR
    Mol Neurobiol; 2007 Feb; 35(1):21-44. PubMed ID: 17519504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
    Matsuoka Y; Picciano M; La Francois J; Duff K
    Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
    Hölscher C
    Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.
    Domingues C; da Cruz E Silva OAB; Henriques AG
    Curr Alzheimer Res; 2017; 14(8):870-882. PubMed ID: 28317487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.